WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Abbott

AbbottAt Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

www.abbott.com

Abbott RSS Channel

Filters
List of articles in category Abbott
Title Published Date
Abbott launches new initiative to drive diversity in medical research and improve care among under-represented populations 03 November 2021
Abbott announces its Pandemic Defense Coalition 12 March 2021
Abbott introduces NeuroSphereâ„¢ Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the U.S. 09 March 2021
Abbott researchers find rare group of people with controlled HIV who could be a key to unlocking cure 02 March 2021
Abbott's fast, $5, 15-minute, easy-to-use COVID-19 antigen test receives FDA Emergency Use Authorization 28 August 2020
Abbott announces discovery of new strain of HIV, keeping global health community a step ahead of the virus 06 November 2019
Abbott and Omada Health partner to offer integrated digital health and coaching experience for people with Type 2 diabetes 14 October 2019
Abbott and Abbott Fund launch 'Future Well Kids' program to help students shape healthier lives 09 October 2019
Abbott announces new data that shows artificial intelligence technology can help doctors better determine which patients are having a heart attack 11 September 2019
Abbott to acquire Cephea Valve Technologies, Inc. 16 January 2019
Abbott recommends rejection of below-market mini-Ttender offer by Baker Mills LLC 14 November 2018
Abbott names Robert B. Ford president, chief operating officer 15 October 2018
Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI) 13 September 2018
A great place to do great things: Developing game-changing technology at Abbott 20 October 2017
Abbott acquisition of Alere set to close on Tuesday, October 3, 2017 02 October 2017
Abbott and the Abbott Fund donate $1 million to support Hurricane Harvey relief efforts 31 August 2017
Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac monitor 08 May 2017
Abbott reports fourth-quarter 2016 results 25 January 2017
Abbott seeks to terminate Alere acquisition 07 December 2016
A great place to work, according to Science 28 October 2016
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • End

Business & Industry

  • CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
  • AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge

Research & Development

  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer
  • Engineered bacteria find tumors, then alert the authorities
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Abbott
  4. Abbott completes acquisition acquisition of privately held eye care company Visiogen

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.